In particular, Jiang et al. proposed α-synuclein (α-Syn) and clusterin loaded in serum exosomes as potential biomarkers that might allow the differentiation of PD patients from other phenotypically similar neurodegenerative movement disorders [205]. This evidence concerns the gene CLU and Parkinson disease.